---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-009240"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T12:00:33.368322+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab Corp. shareholders elect all four director nominees and approve 2025 equity plan

## Summary
- Directors re-elected: Su-Leng Tan Lee, Muhammad Azrul bin Abdul Hamid, Jook Yuen Low, Chee Keong Yap.
- 2025 Equity Incentive Plan approved with 966,759.8 votes for, 10,628.5 against.
- JP Centurion & Partners PLT ratified as independent auditor for FY 2025.
- Adjournment proposal approved if needed to solicit additional proxies.
- All proposals passed; meeting held December 24, 2025.

## SEC filing metadata
- accession: 0001477932-25-009240
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/0001477932-25-009240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-009240
- JSON: https://secwatch.observer/filing/0001477932-25-009240.json
- Plain text: https://secwatch.observer/filing/0001477932-25-009240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.